Loïc Vincent

Loïc VINCENT is a seasoned professional in the biopharmaceutical and biotechnology sectors, currently serving as Chief Scientific Officer at Korro Bio, Inc., a clinical-stage company focused on RNA editing for genetic medicine. VINCENT is also a member of the Scientific Advisory Board for both General Inception and bit.bio, and holds a directorial position on the board of Alaya.bio, which focuses on developing in vivo CAR-T therapies. Previous roles include Chief Scientific Officer at Affini-T Therapeutics, Head of Oncology Drug Discovery and Immunology Units at Takeda, and various leadership positions at Sanofi and Endotis Pharma. VINCENT holds a Ph.D. and a Master of Science in Oncology and Cancer Biology from Université de Rouen, as well as additional qualifications in managing partnerships and licensing.